Overdiagnosis in Colorectal Cancer Screening - Time to Acknowledge A Blind Spot
Overdiagnosis is recognized as a major harm of mammography screening for breast cancer and prostate cancer screening with prostate-specific-antigen (PSA). Colorectal cancer screening is being more broadly implemented in many countries, and screening rates are increasing steadily. Surprisingly, there...
Uloženo v:
| Vydáno v: | Gastroenterology (New York, N.Y. 1943) Ročník 155; číslo 3; s. 592 |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.09.2018
|
| Témata: | |
| ISSN: | 1528-0012, 1528-0012 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Shrnutí: | Overdiagnosis is recognized as a major harm of mammography screening for breast cancer and prostate cancer screening with prostate-specific-antigen (PSA). Colorectal cancer screening is being more broadly implemented in many countries, and screening rates are increasing steadily. Surprisingly, there is a striking and almost complete lack of knowledge about overdiagnosis in colorectal cancer screening. Overdiagnosis is not part of patient information material, hardly mentioned in guidelines, and not addressed in scientific or public debate. The present paper proposes a semantic, conceptual and clinical framework for overdiagnosis in CRC screening. |
|---|---|
| Bibliografie: | SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1 |
| ISSN: | 1528-0012 1528-0012 |
| DOI: | 10.1053/j.gastro.2018.07.037 |